Evidence map›Paper›PMID 39994766›Full record

ArticleBMC medical informatics and decision making2025

Machine learning-based prediction model for patients with recurrent Staphylococcus aureus bacteremia.

Yuan Li, Shuang Song, Liying Zhu, Xiaorun Zhang, Yijiao Mou, Maoxing Lei, Wenjing Wang, Zhen Tao

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuan Li *Department of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nan jing, 210006, China.
Shuang SongDepartment of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nan jing, 210006, China.
Liying ZhuDepartment of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nan jing, 210006, China.
Xiaorun ZhangDepartment of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nan jing, 210006, China.
Yijiao MouDepartment of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nan jing, 210006, China.
Maoxing LeiDepartment of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nan jing, 210006, China.
Wenjing WangDepartment of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nan jing, 210006, China. njmuwwj@yeah.net.
Zhen TaoDepartment of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nan jing, 210006, China. tz1010@126.com.

Funding

Nanjing Medical Science and Technique Development Foundation NMUB20220080
6 · The paper itself

Abstract

backgroundStaphylococcus aureus bacteremia (SAB) remains a significant contributor to both community-acquired and healthcare-associated bloodstream infections. SAB exhibits a high recurrence rate and mortality rate, leading to numerous clinical treatment challenges. Particularly, since the outbreak of COVID-19, there has been a gradual increase in SAB patients, with a growing proportion of (Methicillin-resistant Staphylococcus aureus) MRSA infections. Therefore, we have constructed and validated a pediction model for recurrent SAB using machine learning. This model aids physicians in promptly assessing the condition and intervening proactively.

methodsThe patients data is sourced from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database version 2.2. The patients were divided into training and testing datasets using a 7:3 random sampling ratio. The process of feature selection employed two methods: Recursive Feature Elimination (RFE) and Least Absolute Shrinkage and Selection Operator (LASSO). Prediction models were built using Extreme Gradient Boosting (XGBoost), Random Forest (RF), Logistic Regression (LR), Support Vector Machine (SVM), and Artificial Neural Network (ANN). Model validation included Receiver Operating Characteristic (ROC) analysis, Decision Curve Analysis (DCA), and Precision-Recall Curve (PRC). We utilized SHAP (SHapley Additive exPlanations) values to demonstrate the significance of each feature and explain the XGBoost model.

resultsAfter screening, MRSA, PTT, RBC, RDW, Neutrophils_abs, Sodium, Calcium, Vancomycin concentration, MCHC, MCV, and Prognostic Nutritional Index(PNI) were selected as features for constructing the model. Through combined evaluation using ROC、 DCA and PRC, XGBoost demonstrated the best predictive performance, achieving an AUC value of 0.76 (95% CI: 0.66-0.85) in ROC and 0.56 (95% CI: 0.37-0.75) in PRC. Building a website based on the Xgboost model. SHAP illustrated the feature importance ranking in the XGBoost model and provided examples to explain the XGBoost model.

conclusionsThe adoption of XGBoost for model development holds widespread acceptance in the medical domain. The prediction model for recurrent SAB, developed by our team, aids physicians in timely diagnosis and treatment of patients.

Indexed as

BacteremiaMachine LearningStaphylococcal InfectionsAgedCOVID-19FemaleHumansMaleMethicillin-Resistant Staphylococcus aureusMiddle AgedRecurrenceStaphylococcus aureusMachine learningPrediction modelReadmissionStaphylococcus aureus bacteremiaWeb app

Identifiers

PMID39994766
PMCPMC11853511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.